$PLMR (-2,76%)

Obvious successes

A transformation always involves risks, but Palomar is not just at the beginning of a transformation; it has long since proven that the strategic realignment is successful.

In each of the last three years, profits have jumped by more than 30 % and considerable growth is also expected in the future.

In the first quarter of the current financial year, sales (underwriting revenue) increased by 52% to USD 164.1 million.

Earnings climbed by as much as 72% to USD 1.87 per share, far exceeding expectations of USD 1.58.

As a result, Palomar raised its forecast for annual profit from USD 180 - 192 million to USD 186 - 200 million.

The share then reached a new all-time high of around USD 175 at the end of June and was then sold off - without any news, at least I couldn't find anything relevant.

Outlook and valuation

In the second quarter, sales (underwriting revenue) increased by 48 % to USD 181.6 million.

Earnings climbed by 41% to USD 1.76 per share, once again exceeding expectations of USD 1.68.

As a result, Palomar raised its forecast for net income from USD 186 - 200 million to USD 198 - 208 million.

As a result, the share price fell further and reached a low of USD 110. The share price currently stands at USD 120.86.

As profits are expected to jump by 41% to USD 7.20 per share in the current financial year, Palomar has a forward P/E of 16.8.

The Board of Directors has reacted to this and decided to buy back shares to the value of USD 150 million, which corresponds to around 5% of the market capitalization

Palomar share: chart from 20.08.2025, price: USD 120.86 - symbol: PLMR | Source: TWS

The long-term outlook was confirmed again at the Investor Day in March. Palomar is targeting a doubling of normalized net income to over USD 10 per share by 2027.

Source

https://www.lynxbroker.de/boerse/boerse-kurse/aktien/palomar-aktie/palomar-analyse/?a=3355991664&utm_medium=email&utm_source=newsletter&utm_campaign=newsletter-boersenblick&newsletter=true&mc-rss-cache-bypass=2025082106&goal=0_d93daae099-8a68287b7f-410756260#palomar-vom-erdbeben-spezialisten-zum-wachstumschampion

This week I executed a slightly more capital intensive investment plan than previous weeks thanks to some extra income.

I tried to take advantage of the correction in $PLMR (-2,76%) (my bet for Growth in the insurance sector) and the fall after the capital increase of $AMP (+3,18%) (my speculative bet less and less speculative), as well as giving more weight to the company with the most solid and sustainable dividend in my portfolio, $G (-0,54%) .

The other investments, in Sabre, Allianz and Ping An, are simply the result of a dynamic DCA plan that I have already pre-established based on the evolution of their price compared to the last purchase.

And we have already exceeded €1,000 in portfolio value!

--

This week, I carried out a slightly more capital-intensive investment plan than in previous weeks, thanks to some extra income.

I took the opportunity to buy into the correction of Palomar Holdings (my growth bet within the insurance sector) and the drop following the capital increase of Amper (my speculative pick, becoming less speculative over time), as well as to give more weight to Generali, the company with the most solid and consistent dividend in the portfolio.

The rest of the investments - in Sabre, Allianz, and Ping An - simply follow a dynamic DCA strategy I have pre-established, based on how their prices evolve relative to my previous purchase.

And with this, we've already passed €1,000 in total portfolio value!

As I do every week, I have made new additions to my portfolio following my Dynamic Dollar-Cost Averaging (DAC) strategy through the Trade Republic investment plan. Thus, I continue to apply method and discipline in equal parts to a volatile market, especially in a month of quarterly earnings releases and dividend execution dates.

These have been my purchases for the week:

• $2318 (-1,03%) (5 €): The Chinese insurance sector remains under pressure due to macro uncertainty and the real estate slowdown in China. We took the opportunity to invest in Asia's largest and most technological insurer.
• $SBRE (-1,81%) (19 €): This week they have published results. Analysts were not too pleased with the annual forecast, but they continue to increase market volume and are unique in their niche.
• $AMP (+3,18%) (10 €): continues to move sideways and well below its target value. This month we have learned of the award of new international contracts.
• $PLMR (-2,76%) (20 €): Maintains the same price as last week, so why not increase in a company in which I believe.
• $ALV (-0,75%) (10 €): It is in a support zone and the company is a bug. We must stick to the plan.

Until June 2!

--

As every week, I've made new contributions to my portfolio following my Dynamic Dollar-Cost Averaging (DCA) strategy through Trade Republic's investment plan. This way, I continue applying both method and discipline in a volatile market environment, especially during a month filled with quarterly earnings releases and ex-dividend dates.

These have been my buys this week:

• $2318 (-1,03%) (5 €): The Chinese insurance sector remains under pressure due to macro uncertainty and the ongoing real estate slowdown. A good opportunity to invest in Asia's largest and most tech-driven insurer.

• $SBRE (-1,81%) (19 €): Results were out this week. Analysts weren't too optimistic about the annual guidance, but the company continues to increase market share and stands strong in its niche.

• $AMP (+3,18%) (10 €): The stock remains sideways and well below its target price. This month, they secured new international contracts, which reinforces the company's growth potential.

• $PLMR (-2,76%) (20 €): Price remains unchanged from last week, so why not increase exposure to a company I believe in.

• $ALV (-0,75%) L (10 €): Trading at a key support area. This company is a beast - no reason to deviate from the plan.

See you on June 2nd!

Neither have I entered the world of torcaces, nor is it the name of a new memecoin. Today I started my journey with $PLMR (-2,76%) a US insurer specializing in natural catastrophes and other unusual risks. And it's not doing too badly:

• Combined ratio (return on premiums): 78% (from 100% it is a "loss").
• ROE of 17.46, the third highest in my portfolio.
• A growth growth, partly due to the fact that it does not pay dividends.
• EPS of 4.5.
• Price to book value ratio book value bad for my filter, but we assume: 5.78.

--

I haven't ventured into the world of wood pigeons, nor is this the name of a new memecoin. Today, I've started my position in $PLMR (-2,76%) a U.S. insurance company specialized in natural catastrophes and other uncommon risks. And it's actually doing quite well:

• Combined ratio (profitability relative to premiums): 78% (anything over 100% means underwriting losses)
• ROE of 17.46%, the third highest in my portfolio.
• Strong growthpartly driven by the fact that it doesn't pay dividends.
• EPS of 4.5
• The Price-to-Book ratio is a bit above my usual filter at 5.78, but I'm willing to accept it.